EN DE
Watch Albemarle Corp for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Albemarle Corp (ALB) fair value: what the stock is really worth

As of Nov 4, 2026: fair value (intrinsic value) of Albemarle Corp stock $115, price $94.97, upside +20.7%, quality 44 out of 100. Rating: undervalued. Calculated from audited financials with 9 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Basic Materials US

AC Albemarle Corp logo Thin data Nov 5, 2026

Albemarle Corp

ALB · US
Speculative

The stock costs 17% less than our calculation considers fair.

Fair value $114.60 · Undervalued (17%)
Low debt
Generates free cash flow
1.7% dividend yield · Sustainable
Positive coverage
Revenue last quarter +31% vs. a year ago.
Quality 44/100
Thin margins · 3.8% net margin (TTM) · excl. goodwill write-downs +6.9%
Mixed vs. peers (5/11)
Insiders sold $3.0M (6M)
Weak Growth (revenue 3y −11.1 %/yr in USD)
Narrow moat 42/100 · thin data
Thin data
⟳ Cyclical⚠ Dilution

Risks from the AI analysis

🚩Lithium oversupply concerns erasing prior price gains🚩Sodium-ion batteries could replace lithium in storage🚩Lower-cost Chinese rivals like Ganfeng could undercut prices🚩Chilean state lithium strategy could raise costs or limit output
Watch Albemarle Corp for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$309.13 $49.76 Fair Value $114.60 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 5, 2026.

How to read this chart

60‑month range $49.76 – $309.13 · fair‑value band $68.26 – $168.01 · the $94.97 price screens below the $114.60 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 5, 2026.

Follow Albemarle in your weekly email

Every Wednesday you see whether Albemarle is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen.

Show moreShow less

The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride for use in lithium batteries used in consumer electronics and electric vehicles, power grids and solar panels, high performance greases, specialty glass used in consumer appliances and electronics.

The Specialties segment provides bromine and highly specialized lithium solutions for various industries, such as energy, mobility, connectivity, and health comprising fire safety compounds; bromine-based specialty chemicals products, including elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon, and various bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators.

This segment also provides organic synthesis processes in the areas of steroid chemistry and vitamins, and various life science applications, as well as intermediates in the pharmaceutical industry; technical services, including handling and use of reactive lithium products; and recycling services for lithium-containing by-products.

The Ketjen segment offers clean fuels technologies, including hydroprocessing catalysts together with isomerization and akylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives.

It serves grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals and medical device industries. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.

Stock analysis

Albemarle Corp (ALB) currently trades at $94.97, while our model-based Fair Value estimate is $114.60, implying the stock looks roughly 17% undervalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of $67.41 per share, and 0 of the 9 models we run sit above the $94.97 price.

Bear case: the Growth DCF group reads lowest at $26.20, and 9 of the 9 models stay below the price. Data coverage for this calculation is low.

Scenario range: $68.26 (bear) to $168.01 (bull), the price of $94.97 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 44/100 (below-average quality), in the Basic Materials sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Albemarle Corp reported revenue of $5.1B in FY2025 versus $3.3B in FY2021, a compound +11.5%/yr. Reported net income was −$511M in FY2025.

Key figures

Market cap $12.9B Large · P/E ratio 351.7 · P/S ratio 1.89 · EPS (TTM) $0.2700 · Dividend yield 1.7% · Net margin −9.9% · Return on equity 2.7% · Return on assets (EBIT) 3.8%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).

What moves the price

The share trades about 56% below its 52-week high and 8% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −44% fair-value upside, at 21%, ALB screens cheaper than that median.

Fair Value models

Bear $68.26 Fair Value $114.60 Bull $168.01
Price $94.97 · Upside +20.7%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF $57.46 $94.10 $146.69 77
Growth DCF $57.99 $89.65 $132.03 75
5Y EBITDA Exit $40.15 $67.41 $98.83 72
All 9 models by family
DCF Models
FCF DCF $57.46 $94.10 $146.69 77
5Y Revenue Exit $17.74 $24.95 $32.77 71
5Y EBITDA Exit $40.15 $67.41 $98.83 72
10Y Revenue Exit $32.21 $42.46 $54.23 66
10Y EBITDA Exit $46.11 $70.77 $102.88 66
Multiples
EV/EBITDA $33.60 $49.54 $65.48 66
Asset-Based
NCAV (Graham) $33.13 $44.40 $66.26 54
Growth DCF
Growth DCF $57.99 $89.65 $132.03 75
Rev-Margin DCF $17.74 $26.20 $36.59 70

The fair value above starts from this blend and is adjusted for a cyclical trough year.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 44/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 6
How much profit the company makes from its sales and capital
Quality Growth 67
Are margins and returns getting better?
Cashflow 60
Do the profits arrive as real cash?
Financial strength 50
Debt, balance sheet and risk of trouble
Investment 69
Does it invest with discipline instead of growing at any price?
Low Volatility 24
How calm the share price moves, does not count
Price momentum 21
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 19
Distance to the 52-week high, does not count
New shares 16
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, one officer or director sold shares worth $3.0M and none bought.

  • SaleJ Kent MastersChairman & CEO, Director2× since Mar 10, 2026: 28,176 shares, avg. $178.32$5.0MMay 15, 2026
  • SaleEric NorrisChief Commercial Officer5,692 shares at $165.45$941,741Feb 20, 2026
  • SaleMelissa H. AndersonChief Bus..Transformation Off.8,454 shares at $163.71$1.4MFeb 13, 2026

Plus 12 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 4, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−4.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−11.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.4%
Start year 2020 (pandemic). Over 10 years: +6.2% a year
Revenue growth 32 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.6%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
16.8% (2020) → 1.8% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Growth Forecast

A lot of optimism in the price
The price assumes about as much growth as the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+11.3%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+4.7%
Yearly sales growth analysts expect, extended to five years.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +8.7% a year for the price and +2.3% for the forecasts.
Forecast 2026 (sales)+18.1%
Forecast 2027 (sales)+1.6%
Projected 2028 (sales)+1.6%
Projected 2029 (sales)+1.7%
Projected 2030 (sales)+1.7%

Watch ALB, get fair value alerts →

Recent news

News mood ⓘNews mood, the average tone of recent news (96 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation. Positive
Recent news coverage is more positive than average.
Note from the team Oct 11, 2026
AI conclusion: Resource position offers moderate moat potential yet recent net losses and margin pressure limit durable advantage in this cyclical sector.
Main risk: Sodium-ion batteries from producers like CATL could capture significant share in stationary storage and low-range EVs, reducing demand for Albemarle's lithium chemicals and pressuring volumes and margins.
Bull case: Albemarle could leverage its low-cost Atacama brines and US domestic assets to supply premium lithium for high-performance batteries while sodium-ion takes lower-end segments and partners on recycling to secure feedstock.
Bear case: Widespread adoption of sodium-ion batteries combined with aggressive Chinese supply and Chilean regulatory tightening could structurally erode Albemarle's volumes and force sustained low prices, limiting its ability to fund projects.
Albemarle has cut long-term debt sharply through asset sales and repayments, leaving it with a net debt to EBITDA ratio of 0.5 times and over three billion dollars in liquidity, with no large maturities until late 2028. This stronger balance sheet provides more room to manage lithium price swings while demand for EVs and stationary storage continues to rise. Will the improved financial flexibility prove enough to ride out periods of oversupply, or will faster volume growth from its projects matter more?
Join the discussion →

Compare Albemarle Corp with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 726 stocks

Beats the industry median on 5/11 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 44 · Bottom 25%
Fair Value upside +20.7% · Top 25%
Profitability
Return on equity (12 months) 2.7% · Below median
Return on assets −3.1% · Bottom 25%
Net margin (12 months) 3.8% · Below median
Operating margin (12 months) 27.7% · Top 25%
Growth and dividend
Revenue growth (quarter YoY) 31.1% · Top 25%
Dividend yield (12 months) 1.7% · Above median
Balance sheet
Debt / equity 0.33× · Above median

Valuation Multiplesvs Specialty Chemicals median · lower = cheaper

P/E (12 months) 351.7× · Priciest 25%
PEG 0.79× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)61 · sector 0
FUTURE (revenue growth)100 · sector 67
PAST (return on equity)11 · sector 27
HEALTH (low debt)84 · sector 95
DIVIDEND (yield)34 · sector 30

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Nan Ya Plastics Corporation 1303 249.00 TWD 442.40 TWD +78% vs ALB
Wanhua Chemical Group 600309 ¥73.58 ¥68.03 −8% vs ALB
Linde plc LIN $524.74 $446.62 −15% vs ALB
PPG Industries, Inc PPG $127.27 $77.68 −39% vs ALB
DSM-Firmenich AG DSFIR CHF 103.20 CHF 57.82 −44% vs ALB
Sika AG SIKA CHF 188.75 CHF 98.89 −48% vs ALB
The Sherwin-Williams Company SHW $363.50 $146.37 −60% vs ALB
Givaudan SA GIVN CHF 4,105 CHF 1,554 −62% vs ALB
EMS-CHEMIE HOLDING AG EMSN CHF 859.50 CHF 284.63 −67% vs ALB
Ecolab Inc ECL $315.01 $96.56 −69% vs ALB

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Evidence & backtest34 years, failed companies included Financial calculatorsDCF, Graham, PEG and more
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Albemarle Corp: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Albemarle Corp Fair Value". https://www.fairvalue-calculator.com/stock/ALB

Frequently asked questions

Is Albemarle Corp (ALB) overvalued or undervalued?
As of Nov 5, 2026, our model estimates a fair value of $114.60 versus a price of $94.97, about +21% upside (undervalued).
What is the fair value of ALB?
Our model-based fair value for Albemarle Corp is $114.60 (as of Nov 5, 2026), built from audited fundamentals. The current price: $94.97.
What is the quality score of ALB?
Albemarle Corp has a Quality Score of 44/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Albemarle Corp (ALB)?
Our model-based price target is the fair value of $114.60 (as of Nov 5, 2026) from 9 valuation models. Cautious scenario $68.26, optimistic scenario $168.01. It is a calculation from audited fundamentals, not an analyst target.
What is the Albemarle Corp stock forecast for 2026?
Our models put fair value at $114.60, about +21% upside versus a price of $94.97 (undervalued). Cautious scenario $68.26, optimistic scenario $168.01. The calculation is refreshed regularly with new filings.
What is the revenue of Albemarle Corp (ALB)?
Albemarle Corp reported trailing-twelve-month revenue of about $5.9B (latest available figure, as of Nov 5, 2026).
Does Albemarle Corp pay a dividend?
Albemarle Corp currently shows a dividend yield of 1.71% relative to its recent price (as of Nov 5, 2026).
What growth is priced into Albemarle Corp (ALB)?
For today's price to be fair in a discounted-cash-flow model, Albemarle Corp would have to grow free cash flow by +11.3 % per year for five years (discount rate 10.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +10.5 % per year. As of Nov 5, 2026.
What discount rate (WACC) does the fair value of ALB use?
Our models discount Albemarle Corp at 10.1 %: a base by market capitalisation (large), damped by beta 1.36, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Albemarle Corp that is +11.3 % per year a year over ten years, using the same discount rate (10.1 %) and the same formula as our fair value.
How much growth has Albemarle Corp (ALB) delivered so far?
Over the past 5 years revenue at Albemarle Corp grew +10.5 % a year. The price currently implies +11.3 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Albemarle Corp (ALB) growing?
The median revenue growth in the sector is +9.8 % a year. That is the yardstick for the growth priced into Albemarle Corp (+11.3 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Albemarle Corp (ALB)?
The free-cash-flow yield on the price is 5.35 %: that much free cash flow Albemarle Corp produces per unit of market value. When it exceeds the discount rate of our models (10.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Albemarle Corp (ALB)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Albemarle Corp it is $114.60 per share (as of Nov 5, 2026), against a price of $94.97. It is the blended result of 9 valuation models (cash flow, earnings, asset, dividend).
Is Albemarle Corp stock overvalued or undervalued in 2026?
As of Nov 5, 2026, ALB trades below its calculated fair value: price $94.97, fair value $114.60, a gap of about +21% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ALB?
No. The price is what the market pays today ($94.97); the fair value is what the company's own numbers justify ($114.60). For Albemarle Corp the two are $19.63 per share apart. That gap is exactly why we show both numbers side by side.
How much is Albemarle Corp worth?
The market values Albemarle Corp at about $12.9B (market capitalisation, as of Nov 5, 2026). Per share that is $94.97; our models calculate a fair value of $114.60 per share.
What do the bullish and bearish scenarios say about ALB?
Our models span a range for Albemarle Corp: cautious scenario $68.26, base $114.60, optimistic $168.01 per share (as of Nov 5, 2026, price $94.97). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of ALB?
Albemarle Corp trades at a price-to-earnings ratio of 351.7 (as of Nov 5, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $114.60 is built from several models across several years. Median P/E at fiscal year-end, 8 fiscal years (2016 to 2023), reported earnings: 14.9. Other multiples: PEG 0.8.
What is the PEG ratio of ALB?
The PEG ratio of Albemarle Corp is 0.79 (P/E divided by earnings growth, as of Nov 5, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of Albemarle Corp (ALB)?
Balance-sheet figures for Albemarle Corp (as of Nov 5, 2026): return on equity 2.7%, debt of 0.33 per unit of equity. They feed the Quality Score of 44/100, which measures business quality independently of the share price.
How far is ALB from its 52-week high?
Albemarle Corp trades at $94.97, about 56% below its 52-week high of $215.07 and 8% above the low of $87.74 (as of Nov 4, 2026). Distance from the high says nothing about value: that is what the fair value of $114.60 is for.
Which stocks are comparable to Albemarle Corp?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Nan Ya Plastics Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Albemarle Corp stock attractive at the current price?
The data as of Nov 5, 2026: price $94.97, calculated fair value $114.60 (+21%), Quality Score 44/100, from 9 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ALB calculated?
We run Albemarle Corp through 9 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $114.60, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.6% above its aggregate fair value. Albemarle Corp currently trades 17% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Albemarle Corp (ALB)?
The closing price on Nov 4, 2026 was $94.97. Our model-based fair value is $114.60, about +21% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Albemarle Corp right now?
A fairly wide model range ($68.26 to $168.01) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Albemarle Corp

How large is the market capitalisation of Albemarle Corp (ALB)?
The market capitalisation of Albemarle Corp is $12.9B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Albemarle Corp (ALB)?
The price-to-sales ratio of Albemarle Corp is 1.89 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Albemarle Corp (ALB)?
Earnings per share at Albemarle Corp are $0.2700 (price ÷ EPS = P/E 351.7). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Albemarle Corp (ALB)?
The dividend yield of Albemarle Corp is 1.7%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Albemarle Corp (ALB)?
The net margin of Albemarle Corp is −9.9% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Albemarle Corp (ALB)?
The return on equity (ROE) of Albemarle Corp is 2.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Albemarle Corp (ALB)?
On an EBIT basis the return on assets of Albemarle Corp is 3.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Albemarle Corp (ALB)?
The operating margin of Albemarle Corp is 27.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Albemarle Corp (ALB)?
Revenue at Albemarle Corp is growing +31.1% versus a year earlier (3y avg −11.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Albemarle Corp (ALB)?
Earnings per share at Albemarle Corp are growing −66.2% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Albemarle Corp (ALB) carry?
The net debt of Albemarle Corp is $1.7B (fiscal year 2025, ≈ 2.4 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Albemarle Corp in the live analysis

One click puts Albemarle Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.